Close Menu
Bruker BioSpin Acquisition Completed; BioSciences Reports Profits Up 44 Percent in Q4
The purchase of Bruker BioSpin by Bruker BioSciences has been completed, resulting in the formation of a new company called Bruker, the company said this week.
About 57.5 million new unregistered shares of Bruker’s common stock were issued for the stock component of the deal. At a closing price of $10.86 per share on Feb. 25, the stock portion of the acquisition was approximately $624.9 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

In Science this week: three studies from the Ruminant Genome Project, and more.